Pulmonary Arterial Hypertension Pipeline Insights, 2019 Report - ResearchAndMarkets.com - Odessa American
DUBLIN--(BUSINESS WIRE)--Jan 28, 2019--The "Pulmonary Arterial Hypertension - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
Pulmonary Arterial Hypertension - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pulmonary Arterial Hypertension development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
The report assesses the active Pulmonary Arterial Hypertension pipeline products by developmental stage, product type, molecule type, and administration route.
Key Topics Covered:
1. Report Introduction
2. Pulmonary Arterial Hypertension Overview
3. Pipeline Therapeutics
An Overview of Pipeline Products for Pulmonary Arterial Hypertension
4. Comparative Analysis
5. Products in Clinical Stage
Product DescriptionResearch and DevelopmentProduct Development Activities
6. Products in Pre-Clinical and Discovery Stage
Product DescriptionResearch and DevelopmentProduct Development Activities
7. Therapeutic Assessment
Assessment by Route of AdministrationAssessment by Stage and Route of AdministrationAssessment by Molecule TypeAssessment by Stage and Molecule Type
8. Inactive Products
Product DescriptionResearch and DevelopmentProduct Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/gc3qvt/pulmonary?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190128005380/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
KEYWORD:
INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/28/2019 09:27 AM/DISC: 01/28/2019 09:28 AM
Copyright Business Wire 2019.
http://bit.ly/2sRgFdR
Comments
Post a Comment